p38-MAPK inhibitor MW-150, Purity ≥98%

Cat. No.: X23-10-ZQ914

p38-MAPK inhibitor MW-150, Purity ≥98%

Synonym: MW-150; 1628502-91-9; 6-(4-Methylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)pyridazine; MW150; 6-(4-Methyl-1-piperazinyl)-3-(2-naphthalenyl)-4-(4-pyridinyl)-pyridazine; EPZ68T461K; p38-MAPK inhibitor

  • CAS Number: 1628502-91-9
  • Compound CID: 86270361
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
MW-150 targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates.
Molecular Weight
381.47
Molecular Formula
C24H23N5
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
MW-150 is used in studies targeting microglial p38 MAPK for its potential in modulating neuroinflammation in neurodegenerative diseases.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.